Gene and Cell Therapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section of Biomedicines aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage the submission of manuscripts that provide novel and mechanistic insights and papers that report significant advances on the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- 10th Anniversary of Biomedicines—3D In Vitro Models as an Alternative to Animal Experimentation: Advantages and Pitfalls (Deadline: 31 October 2023)
- Virotherapy and Gene Therapy in Cancer (Deadline: 31 October 2023)
- 10th Anniversary of Biomedicines—Induced Pluripotent Stem Cells: 15 Years after the Discovery (Deadline: 30 November 2023)
- Regulatory T Lymphocytes: Three Decades with Odette-and-Odile in Human Diseases (Deadline: 30 November 2023)
- 10th Anniversary of Biomedicines—Ophthalmology Disorders (Deadline: 31 December 2023)
- Vascular Malformation: From Pathophysiology, Clinical Manifestations to Novel Therapeutic Approaches (Deadline: 31 December 2023)
- Hereditary Metabolic Diseases: The Biological Clock and Innovative Therapies (Deadline: 31 January 2024)
- Advances in Molecular Cytogenetics Volume II (Deadline: 31 January 2024)
- State-of-the-Art Gene-Target and Cell Therapy in Poland (Deadline: 31 January 2024)
- Impact of 3'UTR Variants on mRNA Stability (Deadline: 31 January 2024)
- Mitochondria-Localized Nucleic Acids in Cellular Senescence (Deadline: 31 January 2024)
- The Role of Regulatory T-Cells in Antitumor Immune Response (Deadline: 29 February 2024)
- Omics Approaches on Immune-Mediated Inflammatory Diseases: Towards Novel Biomarkers and Potential Therapeutic Targets Vol. 2 (Deadline: 15 March 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
